Summary
Bovine and human tendon tissue do not induce calcification in vitro. However, extraction of those tissues with 3% Na2HPO4 converts them to calcifiable matrices. The supernatant fraction derived from the extraction contains a nondialyzable, perchloric acid soluble component that inhibits calcification of the extracted matrix. This inhibitory substance is characterized by a molecular weight in the range of 85,000–100,000. Exposure to pronase or hyaluronidase did not alter the inhibitory potency but did render the inhibitor dialyzable. Commercial sources of hyaluronic acid, chondroitin-6-sulfate, chrondroitin-4-sulfate, dermatan sulfate, heparin and lysozyme did not inhibit calcification of the extracted matrix. Phosvitin, a phosphoglycoprotein is a potent inhibitor. Although phosvitin and the tendon extract also inhibit calcification of previously calcified matrix, they have no detectable effect on the rate of decalcification. We conclude that the mechanism of inhibition is characterized by a degree of specificity and that phosvitin and a macromolecular component of tendon tissue blocks conversion of an intermediate matrix-bound CaP complex to crystalline apatite. It seems reasonable that the tendon inhibitor could function in situ and possibly in vivo to control calcification of tendon tissue.
Similar content being viewed by others
References
Glimcher, M.J.: Composition, structure, and organization of bone and other mineralized tissue and the mechanism of calcification. Handbook of Physiology-Endocrinology, Volume VII, 25–116, 1976
Gomori, G.: A modification of the colorimetric phosphorus determination for use with the photoelectric colorimeter. J. Lab. and Clin. Med.27, 955 (1942)
Gruzzuti, K., Perlmann, G.: Further studies on the binding of divalent cations to the phophoglycoprotein phosvitin. Biochemistry14, 2171–2175 (1975)
Howard, J.E., Thomas, W.E., Jr., Barker L.M., Smith, L.H., Wadkins, C.L.: The recognition and isolation from urine and serum of a peptide inhibitor to calcification. Johns Hopkins Med. J.120, 119–136 (1967)
Howell, D.S., Pita, J.C., Marques, J.G., Gatter, R.A.: Demonstration of macromolecular inhibitor(s) of calcification and nucleational factor(s) in fluid from calcifying sites inj cartilage. The J. of Clin. Inv.48, 630–641 (1969)
Luben, R.A., Cohn, D.V.: Effects of parathormone and calcitonin on citrate and hyaluronate metabolism in cultured bone. Endocrinology98, 413–419 (1976)
Luben, R.A., Wadkins, C.L.: Studies of the relationship of proton production and calcification of tendon matrix in vitro. Biochemistry10, 2183–2189 (1971)
Luben, R.A., Groggins, J.F., Raisz, L.G.: Stimulation by parathyroid hormone of bone hyaluronate synthesis in organ culture. Endocrinology94, 737–745 (1975)
Luben, R.A., Sherman, J.K., Wadkins, C.L.: Studies of the mechanism of biological calcification. IV. Ultrastructural analysis of calcifying tendon matrix. Calc. Tiss. Res.11, 39–55 (1972)
Termine, J.D., Posner, A.S.: Calcium phosphate formation in vitro. I. Factors affecting initial phase separation. Arch. Biochem. Biophys.140, 307–318 (1970)
Termine, J.D., Peckauskas, R.A., Posner, A.S.: Calcium phosphate formation in vitro. II. Effects of environment on amorphous-crystalline transformation. Arch. Biochem. Biophys.140, 318–315 (1970)
Thomas, W.C., Jr., Tomita, A.: Mineralization of human and bovine tissues in vitro. Am. J. Pathol.51, 621–628 (1967)
Wadkins, C.L., Luben, R., Thomas, M. and Humphreys, R.: Physical biochemistry of calcification. Clin. Orth.99, 246–266 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quittner, C., Wadkins, C.L. A macromolecular inhibitor of in vitro calcification of tendon matrix. Calc. Tis Res. 25, 161–168 (1978). https://doi.org/10.1007/BF02010764
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02010764